Clinical Trial Update: Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of Botulinum Toxin A in patients with posttraumatic headache; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Headache

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Danish Headache Center | Conditions: Posttraumatic Headache | Phase 3 | Status: RECRUITING